30 results on '"Pauly, Mary"'
Search Results
2. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population
3. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
4. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients
5. Eight- or 12-Week Treatment of Hepatitis C with Ledipasvir/Sofosbuvir: Real-World Experience in a Large Integrated Health System
6. Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
7. Characteristics and Management of Patients with Chronic Hepatitis B in an Integrated Care Setting
8. Reactivation of Hepatitis B (HBV) in Patients Treated with Anti-Tumor Necrosis Factor (anti-TNF) Agents: 72
9. Pseudomembranous colitis without diarrhea presenting clinically as acute intestinal pseudo-obstruction
10. The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan
11. Characteristics and Clinical Management of a Large Cohort of Hepatitis C Patients from a Northern California Integrated Health Plan: 965
12. The Impact of Lifetime Drug Use on Hepatitis C Treatment Outcomes in Privately Insured Members of an Integrated Health Care Plan: 955
13. Chronic Hepatitis B Management in a California Integrated Care Population: 311
14. Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study.
15. Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics
16. Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial
17. Enhancing Electronic Health Systems to End Transmission of Chronic Hepatitis B During COVID‐19: A Collaborative Approach.
18. Serum Fibrosis Marker Panels FIB-4 Index and Aspartate Aminotransferase (AST)-to-Platelet Ratio Index (APRI) Are Equivalent to AST Alone at Predicting Liver Fibrosis in a Cohort of 1731 Patients Infected with Hepatitis C Virus.
19. 450 Simeprevir/Sofosbuvir Therapy in Hepatitis C (HCV) Infected Patients With Child-Pugh Class B/C Cirrhosis Compared to Matched Untreated and Protease Inhibitor (PI)-Triple Therapy Treated Control
20. The impact of lifetime drug use on hepatitis C treatment outcomes in insured members of an integrated health care plan.
21. Effect of Cigarette Smoking on Virologic Response in Patients Treated for Chronic Hepatitis C (CHC) in the IDEAL Study
22. Predictors of Sustained Virologic Response Among Treatment-NaïVE Patients With Hepatitis C Virus Genotype 1 When Treated With Boceprevir (Boc) Plus Peginterferon Alfa-2B-Ribavirin (PR)
23. Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome: four cases and a review.
24. Histopathology of early and late human allograft rejection.
25. A CENTERING, OF SORTS: THE EVOLVING IDEA OF MINNESOTA CENTER FOR BOOK ARTS.
26. Hepatitis C (HCV) patients have a higher cost of care and this is not fully explained by the high number of comorbid conditions
27. Adding new fecal occult blood tests to sigmoidoscopy: What is the added yield?
28. Multicenter randomized trial of 15mcg alfacon-1 administered daily vs.thrice weekly in patients with chronic hepatitis C who did not respond to interferon therapy: Initial response and tolerability
29. Attending IBS class reduces utilization of resources
30. 4 Hepatic fibrosis and cirrhosis in tropical countries (including portal hypertension)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.